ScholarIQanswers from OpenAlex

Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target

PaperCitations, authors & open-access status

Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target have?

ScholarIQcitation count

Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target has 32 citations in the OpenAlex counts ScholarIQ stores.

When was Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target published?

ScholarIQyear

Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target has 2019 year in the ScholarIQ index.

What is the open-access status of Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target?

ScholarIQoa status

Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target has bronze oa status in the ScholarIQ index.

What is the DOI of Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target?

ScholarIQdoi

The DOI for Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target is on the source record.

What is the PMID of Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target?

ScholarIQpmid

The PMID for Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target is on the source record.

What is the OpenAlex record for Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target?

ScholarIQopenalex

The OpenAlex for Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial